MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Ataxia: Treatment"

  • 2026 International Congress

    Clinical Profile, Therapeutic Interventions, and Outcome Predictors of Paraneoplastic Movement Disorders – A Tertiary Care Centre Experience

    A. Vijayaraghavan (Thiruvananthapuram, India)

    Objective: To analyze the clinical spectrum, associated tumors, antibody profile, outcomes, and prognostic predictors in a cohort of paraneoplastiic movement disorders admitted in a tertiary…
  • 2026 International Congress

    Repetitive Transcranial Magnetic Stimulation Improves Static Balance Control in Cerebellar Ataxia

    S. Lee, J. Ro, M. Jung, H-W. Lee (Daegu, Republic of Korea)

    Objective: Repetitive transcranial magnetic stimulation (rTMS) has shown promise in improving motor functions in other movement disorders. This pilot study aimed to investigate the effects…
  • 2026 International Congress

    Interventions in Friedreich’s Ataxia and their Influence on Patient-centric Outcomes: A Systematic Review

    D. Sarwinska, M. Buchholz, A. Iskandar, M. Grobe-Einsler, T. Klockgether, J. Faber, B. Michalowsky (Greifswald, Germany)

    Objective: The presented systematic review summarizes available pharmacological and non‑pharmacological interventions for patients with Friedreich's ataxia, their outcomes, and alignment with patient‑centered health domains as…
  • 2026 International Congress

    Intravenous AAVrh.10hFXN (LX2006) Gene Therapy in Friedreich Ataxia: Early Neurologic Assessment from Two Phase 1 and 2 Studies

    T. Zesiewicz, T. Vu, J. Weinsalft, S. Kaminsky, A. Patel, R. Gavrilova, S. Perlman, U. Krishnan, M. Galbraith, N. Savage, R. Kaner, M. Vo, H. Sarva, A. Yoo, D. Sondhi, C. Rummey, G. Aubert, A. Khan, S. Ghanekar, R. Crystal (Tampa, USA)

    Objective: To evaluate neurologic measures of efficacy of intravenous AAVrh.10hFXN (LX2006) gene therapy in adults with Friedreich ataxia, based on data from the SUNRISE-FA study…
  • 2026 International Congress

    Positive Results from a Global Phase 3 Trial (IB1001-303) Evaluating Levacetylleucine in Ataxia-Telangiectasia

    B. Zanrucha, M. Patterson, T. Bremova-Ertl, M. Strupp, J. Raymond, J. Kerthi, T. Fields, I. Billington, K. Martakis (Austin, USA)

    Objective: To report efficacy and safety findings from the pivotal, Phase 3 trial evaluating levacetylleucine in children and adults with Ataxia-Telangiectasia (A-T). Background: A-T is…
  • 2026 International Congress

    A Phase 3, Multinational, Randomized, Placebo-Controlled, Double-Blind, Crossover Trial (IB1001-304) Evaluating Levacetylleucine in CACNA1A Disorders

    B. Zanrucha, T. Bremova-Ertl, M. Patterson, M. Strupp, J. Kerthi, J. Raymond, T. Fields, I. Billington, K. Martakis (Austin, USA)

    Objective: To assess the efficacy, safety, and tolerability of levacetylleucine in people with CACNA1A disorders. Background: CACNA1A disorders refer to a range of rare, progressive,…
  • 2026 International Congress

    Transitional Life Events in Friedreich Ataxia: Differential Age at Onset Perspectives

    A. Iskandar, D. Sarwinska, T. Klockgether, S. Borel, F. Xie, E. Davies, K. Reetz, T. Klopstock, L. Schöls, S. Boesch, M. Buchholz, B. Michalowsky (Greifswald, Germany)

    Objective: To identify and quantify the age-contingent impact of Friedreich’s Ataxia. Background: Friedreich's ataxia (FA) is a rare, inherited multisystem neurodegenerative disorder that primarily affects…
  • 2026 International Congress

    Effects of a Six-Week Neurorehabilitation Program on Ataxia, Balance and Gait in a Patient with CANVAS Syndrome: A Case Report

    M. Salamci, A. Guclu-Gunduz, M. Akbostanci (Ankara, Turkey)

    Objective: This study aimed to examine the effects of a neurologic physiotherapy on ataxia, balance, and gait in a patient with cerebellar ataxia, neuropathy, and…
  • 2026 International Congress

    Healthcare Utilization and Economic Burden in Patients with Friedreich’s Ataxia: Baseline Results of the PROFA Study

    D. Sarwinska, A. Iskandar, M. Buchholz, T. Klockgether, S. Borel, F. Xie, E. Davies, K. Reetz, L. Schöls, T. Klopstock, S. Boesch, B. Michalowsky (Greifswald, Germany)

    Objective: The study aimed to investigate healthcare utilization, costs, and the distribution of costs across ambulation levels among patients with Friedreich's ataxia. Background: Friedreich's ataxia…
  • 2026 International Congress

    An interesting case of progressive vision loss and unusual gait

    A. Kumar, S. Kumar (Patna, India)

    Objective: To highlight the importance of vision diminution and improvement with drugs a clue for treatable disorder like abetalipoproteinemia. Background: A 22 years old male…
  • 1
  • 2
  • 3
  • …
  • 10
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley